Skip to content

Author

Jie Zhang

We have 1 of 19 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

A Pilot Clinical Trial of Cetuximab Combined With Tislelizumab as Neoadjuvant Therapy for Locally Advanced Oral Squamous Cell Carcinoma.

Neoadjuvant cetuximab plus tislelizumab plus tislelizumab showed feasible delivery, encouraging antitumor activity, and acceptable safety in patients with locally advanced oral squamous cell carcinoma who were medically unsuitable for conventional cytotoxic chemotherapy.

Wen-Jie Wu, Pu-Gen An, Xiao Hu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.